Zdrowie i gospodarka · 15/11/2010

Medicaid Program; Withdrawal of Determination of Average Manufacturer Price, Multiple Source Drug Definition, and Upper Limits for Multiple Source Drugs

This final rule withdraws two provisions from the "Medicaid Program; Prescription Drugs" final rule (referred to hereafter as "AMP final rule") published in the July 17, 2007 Federal Register. The provisions we are withdrawing are as follows: The determination of average manufacturer price, and the Federal upper limits for multiple source drugs. We are also withdrawing the definition of "multiple source drug" as it was revised in the "Medicaid Program; Multiple Source Drug Definition" final rule published in the October 7, 2008 Federal Register.